These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 8035397)

  • 1. Body lead stores and urate excretion in men with chronic renal disease.
    Lin JL; Huang PT
    J Rheumatol; 1994 Apr; 21(4):705-9. PubMed ID: 8035397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lead chelation therapy and urate excretion in patients with chronic renal diseases and gout.
    Lin JL; Yu CC; Lin-Tan DT; Ho HH
    Kidney Int; 2001 Jul; 60(1):266-71. PubMed ID: 11422760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal function in minahasanese patients with chronic gout arthritis and tophi.
    Wibowo C; Kaparang AM; Moeis ES; Kapojos AL
    Acta Med Indones; 2005; 37(2):61-65. PubMed ID: 20066786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated lead burden in Chinese patients without occupational lead exposure.
    Lin JL; Lim PS
    Miner Electrolyte Metab; 1992; 18(1):1-5. PubMed ID: 1406500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary nephropathy associated with hyperuricemia and gout.
    Puig JG; Miranda ME; Mateos FA; Picazo ML; Jiménez ML; Calvin TS; Gil AA
    Arch Intern Med; 1993 Feb; 153(3):357-65. PubMed ID: 8427538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Environmental lead exposure and progression of chronic renal diseases in patients without diabetes.
    Lin JL; Lin-Tan DT; Hsu KH; Yu CC
    N Engl J Med; 2003 Jan; 348(4):277-86. PubMed ID: 12540640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Environmental lead exposure and urate excretion in the general population.
    Lin JL; Tan DT; Ho HH; Yu CC
    Am J Med; 2002 Nov; 113(7):563-8. PubMed ID: 12459402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does lead play a role in the development of renal insufficiency in some patients with essential hypertension?
    Lin JL; Lim PS
    J Hum Hypertens; 1994 Jul; 8(7):495-500. PubMed ID: 7932512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients.
    Caspi D; Lubart E; Graff E; Habot B; Yaron M; Segal R
    Arthritis Rheum; 2000 Jan; 43(1):103-8. PubMed ID: 10643705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher therapeutic plasma oxypurinol concentrations might be required for gouty patients with chronic kidney disease.
    Panomvana D; Sripradit S; Angthararak S
    J Clin Rheumatol; 2008 Feb; 14(1):6-11. PubMed ID: 18431090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of low dose daily aspirin on serum urate levels and urinary excretion in patients receiving probenecid for gouty arthritis.
    Harris M; Bryant LR; Danaher P; Alloway J
    J Rheumatol; 2000 Dec; 27(12):2873-6. PubMed ID: 11128679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urate kinetics in hypoxanthine-guanine phosphoribosyltransferase deficiency: their significance for the understanding of gout.
    Emmerson BT; Gordon RB; Johnson LA
    Q J Med; 1976 Jan; 45(177):49-61. PubMed ID: 769040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermittent elevation of serum urate and 24-hour urinary uric acid excretion.
    Yu KH; Luo SF; Tsai WP; Huang YY
    Rheumatology (Oxford); 2004 Dec; 43(12):1541-5. PubMed ID: 15328425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of low level lead exposure on hyperuricemia and gout among middle aged and elderly men: the normative aging study.
    Shadick NA; Kim R; Weiss S; Liang MH; Sparrow D; Hu H
    J Rheumatol; 2000 Jul; 27(7):1708-12. PubMed ID: 10914856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occult lead intoxication as a cause of hypertension and renal failure.
    Sánchez-Fructuoso AI; Torralbo A; Arroyo M; Luque M; Ruilope LM; Santos JL; Cruceyra A; Barrientos A
    Nephrol Dial Transplant; 1996 Sep; 11(9):1775-80. PubMed ID: 8918621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gout attacks in chronic alcoholics occur at lower serum urate levels than in nonalcoholics.
    Vandenberg MK; Moxley G; Breitbach SA; Roberts WN
    J Rheumatol; 1994 Apr; 21(4):700-4. PubMed ID: 8035396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
    Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N
    Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP; Leung KT; Tong MK; Kwan TH
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine-induced hyperuricemia and gout.
    Lin HY; Rocher LL; McQuillan MA; Schmaltz S; Palella TD; Fox IH
    N Engl J Med; 1989 Aug; 321(5):287-92. PubMed ID: 2664517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occult lead intoxication in patients with gout and kidney disease.
    Wright LF; Saylor RP; Cecere FA
    J Rheumatol; 1984 Aug; 11(4):517-20. PubMed ID: 6434739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.